Lung Cancer Clinical Trials

Showing 4201-4220 of 4,288 trials

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

NCT01004601

Docetaxel and pemetrexed have been validated for previously treated advanced non-small cell lung cancer (NSCLC); however, tolerability is a concern with the docetaxel (tri-weekly 75 mg/m2 schedule). The investigators conducted this study to compare the efficacy and toxicity of weekly low-dose docetaxel versus tri-weekly pemetrexed for previously treated advanced NSCLC.

Non Small Cell Lung Cancer

Chang Gung Memorial Hospital179 participantsStarted Mar 2005

Taipei, Taipei, Taiwan

TERMINATEDPhase 1/2

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

NCT00447421

The purpose of this study is to determine the recommended dose of pemetrexed, cisplatin and radiotherapy in the treatment of patients with Small Cell Lung Cancer.

Small Cell Lung CancerCarcinoma, Small CellSCLC

Eli Lilly and Company9 participantsStarted Feb 2007

Leuven, Belgium • 's-Hertogenbosch, Netherlands • Amsterdam, Netherlands +1 more locations

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Related Searches

The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer

Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC

Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy

HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma

Phase II Iressa Versus Vinorelbine (INVITE)

Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions

Study of Picoplatin Efficacy After Relapse